Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: Opportunistic retrospective study of medical charts in China

Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: Opportunistic retrospective study of medical charts in China

Taispeáin leaganacha eile (1)

Objective: To describe the clinical features and effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A(H1N1) virus infection. Design: Opportunistic retrospective review of medical charts of patients with confirmed 2009 H1N1 identif...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Yu, H, Liao, Q, Yuan, Y, Zhou, L, Xiang, N, Huai, Y, Guo, X, Zheng, Y, Van Doorn, H, Farrar, J, Gao, Z, Feng, Z, Wang, Y, Yang, W
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	2010

Míreanna comhchosúla

Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China.
de réir: Yu, H, et al.
Foilsithe / Cruthaithe: (2010)

A community cluster of oseltamivir-resistant cases of 2009 H1N1 influenza.
de réir: Le, Q, et al.
Foilsithe / Cruthaithe: (2010)

A community cluster of oseltamivir-resistant cases of 2009 H1N1 influenza
de réir: Mai, L, et al.
Foilsithe / Cruthaithe: (2010)

Oseltamivir resistance during treatment of influenza A (H5N1) infection.
de réir: Jong, d, et al.
Foilsithe / Cruthaithe: (2005)

Inhibitory activity of selenium nanoparticles functionalized with oseltamivir on H1N1 influenza virus
de réir: Li Y, et al.
Foilsithe / Cruthaithe: (2017-08-01)

Oseltamivir- and Amantadine-Resistant Influenza Viruses A (H1N1)
de réir: Peter K.C. Cheng, et al.
Foilsithe / Cruthaithe: (2009-06-01)

Oseltamivir resistance in influenza A (H5N1) infection - Reply
de réir: Jong, d, et al.
Foilsithe / Cruthaithe: (2006)

Viral shedding in children infected by pandemic A/H1N1/2009 influenza virus
de réir: Fossali Emilio, et al.
Foilsithe / Cruthaithe: (2011-07-01)

Oseltamivir-Resistant Influenza Viruses A (H1N1) during 2007–2009 Influenza Seasons, Japan
de réir: Makoto Ujike, et al.
Foilsithe / Cruthaithe: (2010-06-01)

Inhibition of Influenza Virus Replication by Oseltamivir Derivatives
de réir: Renee W. Y. Chan, et al.
Foilsithe / Cruthaithe: (2022-02-01)

Oseltamivir storage, distribution and dispensing following the 2009 H1N1 influenza outbreak in Mexico
de réir: Luis Meave Gutiérrez-Mendoza, et al.

Viral shedding in patients infected with pandemic influenza A (H1N1) virus in Kenya, 2009.
de réir: Lilian W Waiboci, et al.
Foilsithe / Cruthaithe: (2011-01-01)

Prolonged Viral Shedding in Cancer Patients with Asymptomatic or Mild Omicron Infection: A Retrospective Study
de réir: Yang Q, et al.
Foilsithe / Cruthaithe: (2023-12-01)

Sales of oseltamivir in Norway prior to the emergence of oseltamivir resistant influenza A(H1N1) viruses in 2007–08
de réir: Hungnes Olav, et al.
Foilsithe / Cruthaithe: (2009-05-01)

Oseltamivir for treatment and prevention of pandemic influenza A/H1N1 virus infection in households, Milwaukee, 2009
de réir: Miller Joel C, et al.
Foilsithe / Cruthaithe: (2010-07-01)

Low dose influenza virus challenge in the ferret leads to increased virus shedding and greater sensitivity to oseltamivir.
de réir: Anthony C Marriott, et al.
Foilsithe / Cruthaithe: (2014-01-01)

Oseltamivir-resistant pandemic (H1N1)2009 in Yemen - case report
de réir: Al-Kohlani Abdulhakeem, et al.
Foilsithe / Cruthaithe: (2010-05-01)

Combination therapy of nitazoxanide with oseltamivir compared with oseltamivir in hospitalized patients with seasonal influenza
de réir: Parvaiz A Koul, et al.
Foilsithe / Cruthaithe: (2024-01-01)

Possible neuropsychiatric reaction to high-dose oseltamivir during acute 2009 H1N1 influenza A infection.
de réir: Nakamura, K, et al.
Foilsithe / Cruthaithe: (2010)

Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus, Mexico
de réir: José Ernesto Ramirez-Gonzalez, et al.
Foilsithe / Cruthaithe: (2011-02-01)

Possible Transmission of Pandemic (HIN1) 2009 Virus with Oseltamivir Resistance
de réir: Michal Mandelboim, et al.
Foilsithe / Cruthaithe: (2010-05-01)

Comparison of oseltamivir and α-galactosylceramide for reducing disease and transmission in pigs infected with 2009 H1N1 pandemic influenza virus
de réir: Darling Melany de C. Madrid, et al.
Foilsithe / Cruthaithe: (2022-10-01)

Pandemic (H1N1) 2009 and Oseltamivir Resistance in Hematology/Oncology Patients
de réir: Cameron Wolfe, et al.
Foilsithe / Cruthaithe: (2010-11-01)

Oseltamivir-Resistant Pandemic (H1N1) 2009 Treated with Nebulized Zanamivir
de réir: Liviana Da Dalt, et al.
Foilsithe / Cruthaithe: (2010-11-01)

OSELTAMIVIR AS ANTIVIRAL THERAPY OF INFLUENZA A(H1N1)pdm09 IN CHILDREN AND ADULTS
de réir: L. V. Osidak, et al.
Foilsithe / Cruthaithe: (2016-09-01)

Monitoring and Characterization of Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus, Japan, 2009–2010
de réir: Makoto Ujike, et al.
Foilsithe / Cruthaithe: (2011-03-01)

Comparative effectiveness of combined favipiravir and oseltamivir therapy versus oseltamivir monotherapy in critically ill patients with influenza virus infection
de réir: Wang, Y, et al.
Foilsithe / Cruthaithe: (2019)

Oseltamivir for the treatment of influenza in children and adolescents
de réir: Alfredo Tagarro, et al.
Foilsithe / Cruthaithe: (2019-05-01)

Oseltamivir compounding in the hospital pharmacy during the (H1N1) influenza pandemic
de réir: Márcia Lúcia de Mário Marin, et al.
Foilsithe / Cruthaithe: (2010-01-01)

Detection of oseltamivir-resistant pandemic influenza A(H1N1)pdm2009 in Brazil: can community transmission be ruled out?
de réir: Thiago Moreno L Souza, et al.
Foilsithe / Cruthaithe: (2013-01-01)

Correlation of Pandemic (H1N1) 2009 Viral Load with Disease Severity and Prolonged Viral Shedding in Children
de réir: Chung-Chen Li, et al.
Foilsithe / Cruthaithe: (2010-08-01)

A two-year survey of the oseltamivir-resistant influenza A(H1N1) virus in Yamagata, Japan and the clinical effectiveness of oseltamivir and zanamivir
de réir: Itagaki Tsutomu, et al.
Foilsithe / Cruthaithe: (2010-03-01)

Assessing the viral fitness of oseltamivir-resistant influenza viruses in ferrets, using a competitive-mixtures model.
de réir: Hurt, A, et al.
Foilsithe / Cruthaithe: (2010)

Oseltamivir-Resistant Pandemic (H1N1) 2009 in Patient with Impaired Immune System
de réir: Grant A. Hill-Cawthorne, et al.
Foilsithe / Cruthaithe: (2010-07-01)

Characteristics of Patients with Oseltamivir-Resistant Pandemic (H1N1) 2009, United States
de réir: Samuel B. Graitcer, et al.
Foilsithe / Cruthaithe: (2011-02-01)

Adherence to Oseltamivir Guidelines during Influenza Pandemic, the Netherlands
de réir: Esther H. Fietjé, et al.
Foilsithe / Cruthaithe: (2012-03-01)

Susceptibility of influenza A(H1N1)/pdm2009, seasonal A(H3N2) and B viruses to Oseltamivir in Guangdong, China between 2009 and 2014
de réir: Shan-shan Liu, et al.
Foilsithe / Cruthaithe: (2017-08-01)

Does Oseltamivir Really Reduce Complications of Influenza?
de réir: Del Mar, C, et al.
Foilsithe / Cruthaithe: (2011)

Oseltamivir is adequately absorbed following nasogastric administration to adult patients with severe H5N1 influenza.
de réir: Taylor, W, et al.
Foilsithe / Cruthaithe: (2008)

Occurrence and characterization of oseltamivir-resistant influenza virus in children between 2007-2008 and 2008-2009 seasons
de réir: Seoung Geun Kim, et al.
Foilsithe / Cruthaithe: (2013-04-01)